Answers are grounded in this paper and cite their sources.
Commentary explores rare missense variants in APOE and their implications for Alzheimer's disease genetics, suggesting pathways for therapeutic development.
The apolipoprotein E ( APOE ) gene is the most robust genetic risk factor for Alzheimer's disease (AD), with the ε4 allele conferring elevated risk and ε2 providing protection. While research has largely focused on common variants, recent findings by Miyashita et al. highlight the role of rare missense variants (RMVs) such as APOE ε7, composed of p.E262 K and p.E263 K within the C-terminal lipid-binding domain. These results reinforce the functional heterogeneity of APOE and suggest that rare variants may also modulate AD susceptibility. This commentary discusses the implications of such findings for APOE -targeted therapeutic development, the necessity of functional validation, and the importance of expanding cross-ethnic research efforts to uncover variant-specific effects. Understanding rare protective variants like APOE ε7 could provide natural models for drug discovery and help reconcile ongoing paradoxes in APOE biology, including the nuanced role of ε4 in different molecular contexts.
No takes yet. Share an insight, caveat, or question.
Jungsoo Gim (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: